Cargando…

Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide

Salusin-β is an endogenous parasympathomimetic proatherosclerotic peptide. Salusin-β was initially predicted from bioinformatic analyses and later immunologically detected in human biofluids. However, elucidation of salusin-β bioactivity has faced enormous challenges because of its unique physicoche...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujimoto, Kazumi, Hayashi, Akinori, Kodera, Yoshio, Saito, Tatsuya, Toki, Takuya, Ogawa, Akifumi, Kamata, Yuji, Takano, Koji, Katakami, Hideki, Shichiri, Masayoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557946/ https://www.ncbi.nlm.nih.gov/pubmed/28811505 http://dx.doi.org/10.1038/s41598-017-08288-0

Ejemplares similares

Circulating Levels of Human salusin-β,a Potent Hemodynamic and Atherogenesis Regulator
por: Fujimoto, Kazumi, et al.
Publicado: (2013)

Correction: Circulating Levels of Human Salusin-β, a Potent Hemodynamic and Atherogenesis Regulator
por: Fujimoto, Kazumi, et al.
Publicado: (2013)

Salusin-β as a powerful endogenous antidipsogenic neuropeptide
por: Suzuki-Kemuriyama, Noriko, et al.
Publicado: (2016)

Methionine sulfoxides in serum proteins as potential clinical biomarkers of oxidative stress
por: Suzuki, Satoko, et al.
Publicado: (2016)

Identification of the salusin-β receptor using proteoliposomes embedded with endogenous membrane proteins
por: Shichiri, Masayoshi, et al.
Publicado: (2018)

Molecular form and concentration of serum α(2)-macroglobulin in diabetes
por: Yoshino, Sonomi, et al.
Publicado: (2019)

Salusins: Potential Use as a Biomarker for Atherosclerotic Cardiovascular Diseases
por: Sato, Kengo, et al.
Publicado: (2013)

Levels of albuminuria and risk of developing macroalbuminuria in type 2 diabetes: historical cohort study
por: Chida, Shoma, et al.
Publicado: (2016)

GIP_HUMAN[22–51] is a new proatherogenic peptide identified by native plasma peptidomics
por: Masaki, Tsuguto, et al.
Publicado: (2021)

Short-term Change in Resting Energy Expenditure and Body Compositions in Therapeutic Process for Graves' Disease
por: Hayashi, Akinori, et al.
Publicado: (2020)

New Indices for Predicting Glycaemic Variability
por: Ogawa, Akifumi, et al.
Publicado: (2012)

Serum salusin-α and salusin-β levels in patients with psoriatic arthritis
por: Kobak, Senol, et al.
Publicado: (2022)

Salusin-β is superior to salusin-α as a marker for evaluating coronary atherosclerosis
por: Wang, Yuxue, et al.
Publicado: (2020)

Robust increase in glucagon secretion after oral protein intake, but not after glucose or lipid intake in Japanese people without diabetes
por: Ichikawa, Raishi, et al.
Publicado: (2023)

Suprabasin-derived bioactive peptides identified by plasma peptidomics
por: Taguchi, Tomomi, et al.
Publicado: (2021)

ANGT_HUMAN[448–462], an Anorexigenic Peptide Identified Using Plasma Peptidomics
por: Sasaki, Sayaka, et al.
Publicado: (2022)

A Case With Adult GH Deficiency Complicated With Osteogenesis Imperfecta: Effect of GH Replacement on Bone Mineral Density
por: Taguchi, Tomomi, et al.
Publicado: (2021)

Salusin beta, atherosclerosis, and coronary slow flow
por: Akıncı, Sinan, et al.
Publicado: (2020)

Endogenous Bioactive Peptides as Potential Biomarkers for Atherosclerotic Coronary Heart Disease
por: Watanabe, Takuya, et al.
Publicado: (2012)

Oxidised Met(147) of human serum albumin is a biomarker of oxidative stress, reflecting glycaemic fluctuations and hypoglycaemia in diabetes
por: Momozono, Akari, et al.
Publicado: (2020)

Effects of canagliflozin on body composition and hepatic fat content in type 2 diabetes patients with non‐alcoholic fatty liver disease
por: Inoue, Mitsuko, et al.
Publicado: (2019)

Effects of Two Types of Moderate- and High-Intensity Interval Training on Serum Salusin-α and Salusin-β Levels and Lipid Profile in Women with Overweight/Obesity
por: Nazari, Maryam, et al.
Publicado: (2020)

Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy
por: Zhao, Ming-Xia, et al.
Publicado: (2017)

Relationship of serum salusin beta levels with coronary slow flow
por: Akyüz, Aydın, et al.
Publicado: (2019)

A New Marker for Determining Cardiovascular Risk: Salusin Alpha
por: Yılmaz, Emre, et al.
Publicado: (2022)

Salusin-β Not Salusin-α Promotes Vascular Inflammation in ApoE-Deficient Mice via the I-κBα/NF-κB Pathway
por: Zhou, Cheng-Hua, et al.
Publicado: (2014)

Salusin-β, but Not Salusin-α, Promotes Human Umbilical Vein Endothelial Cell Inflammation via the p38 MAPK/JNK-NF-κB Pathway
por: Zhou, Cheng-Hua, et al.
Publicado: (2014)

Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population?
por: Kołakowska, Urszula, et al.
Publicado: (2014)

The Clinical Significance of Salusins in Systemic Sclerosis—A Cross-Sectional Study
por: Nowaczyk, Joanna, et al.
Publicado: (2023)

Overexpression of Salusin-α Inhibits Vascular Intimal Hyperplasia in an Atherosclerotic Rabbit Model
por: Qian, Kun, et al.
Publicado: (2018)

Silencing salusin-β attenuates cardiovascular remodeling and hypertension in spontaneously hypertensive rats
por: Ren, Xing-Sheng, et al.
Publicado: (2017)

Central blockade of salusin β attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats
por: Li, Hong-Bao, et al.
Publicado: (2015)

Targeted Delivery of Salusin‐α Into Rabbit Carotid Arterial Endothelium Using SonoVue
por: Wang, Yuxue, et al.
Publicado: (2021)

The role of adropin, salusin-α, netrin-1, and nesfatin-1 in endometriosis and their association with insulin resistance
por: Akbaba, Eren, et al.
Publicado: (2021)

Brain, Liver, and Serum Salusin-alpha and -beta Alterations in Sprague-Dawley Rats with or without Metabolic Syndrome
por: Citil, Cihan, et al.
Publicado: (2014)

Measurement of salusin-ß without the addition of NP-40 or Tween-20 in coronary slow-flow phenomenon
por: Aydın, Suna, et al.
Publicado: (2020)

Salusin-β in Intermediate Dorsal Motor Nucleus of the Vagus Regulates Sympathetic-Parasympathetic Balance and Blood Pressure
por: Wu, Lu-Lu, et al.
Publicado: (2021)

Knockdown of Salusin-β Improves Cardiovascular Function in Myocardial Infarction-Induced Chronic Heart Failure Rats
por: Xu, Yu, et al.
Publicado: (2021)

The effect of salusin-β on expression of pro- and anti-inflammatory cytokines in human umbilical vein endothelial cells (HUVECs)
por: Esfahani, Maryam, et al.
Publicado: (2018)

Salusin-β mediates tubular cell apoptosis in acute kidney injury: Involvement of the PKC/ROS signaling pathway
por: Lu, Qing-Bo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_egtn50ggplv79s06qliqs8p9s1